Drug Profile
Vorsetuzumab
Alternative Names: h1F6; SGN-70Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Seattle Genetics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; CD70 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; Cancer; Inflammation; Plaque psoriasis